KEDEM PHARMACEUTICALS INC.
CIK 0001376228
Revenue (TTM)
—
Q2 Dec 2012
Net Income (TTM)
−$4.66M
−41.6% YoY
Q2 Dec 2012
EPS Diluted (TTM)
—
Q2 Dec 2012
Gross Margin
—
Q2 Dec 2012
Operating Margin
—
Q2 Dec 2012
Net Margin
—
Q2 Dec 2012
Free Cash Flow (TTM)
—
Q2 Dec 2012
Cash
$54.17K
Q2 Dec 2012
Total Debt
—
Q2 Dec 2012
Shares Outstanding
25.39M sh
Q2 Dec 2012
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.